Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


30 octubre 2013

STROKE. Clinical Sciences. Does Sex Influence the Response to Intravenous Thrombolysis in Ischemic Stroke?

Svetlana Lorenzano, MD, PhD, MSc; Niaz Ahmed, MD, PhD; Anne Falcou, MD, PhD; Robert Mikulik, MD, PhD; Turgut Tatlisumak, MD, PhD; Christine Roffe, MD; Nils Wahlgren, MD, PhD; Danilo Toni, MD, PhD, FESO on behalf of the SITS Investigators

Background and Purpose: Women are more likely to have a worse outcome after an acute stroke than men. Some studies have suggested that women also benefit less from intravenous thrombolysis after an acute ischemic stroke, but others found no sex differences in safety and efficacy. We aimed to evaluate differences in 3-month outcome between sexes in intravenous tissue-type plasminogen activator–treated patients registered in the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register.

03 octubre 2013

STROKE. Brief Report. Extradural Internal Carotid Artery Caliber Dysregulation Is Associated With Cerebral Aneurysms

Sarah Schimansky, BSc; Samir Patel, BSc; Jason Rahal, MD; Alexandra Lauric, PhD; Adel M. Malek, MD, PhD

Background and Purpose: Flow-induced hemodynamic forces are critical in extra- and intracranial arterial caliber regulation and have been proposed to mediate intracranial aneurysm (IA) formation and rupture. We hypothesized that vascular structural control may be impaired in patients harboring brain aneurysms and sought to examine any differences in extradural internal carotid artery (ICA) caliber profiles.

17 octubre 2013

STROKE. Brief Report. Intracranial Stent Placement for Symptomatic Intracranial Stenosis as Part of a Clinical Trial Versus Outside a Clinical Trial

Farhan Siddiq, MD; Malik M. Adil, MD; Kiersten Norby, MD; Adnan I. Qureshi, MD

Background and Purpose: A high rate of postprocedure complications in the Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) trial has raised concerns whether such results are representative of intracranial stent placement in actual routine practice.

01 marzo 2014

AMERICAN JOURNAL OF ROENTGENOLOGY. Safety and Efficacy of Percutaneous Vertebroplasty and Interventional Tumor Removal for Metastatic Spinal Tumors and Malignant Vertebral Compression Fractures

Yi-Feng Gu1, Yong-Dong Li, Chun-Gen Wu, Zhen-Kui Sun and Cheng-Jian He

OBJECTIVE. The purpose of this study was to determine the safety and efficacy of percutaneous vertebroplasty and interventional tumor removal in the management of metastatic spinal tumors and malignant vertebral compression fractures.

01 enero 2014

RADIOLOGY. MR Selective Flow-Tracking Cartography: A Postprocessing Procedure Applied to Four-dimensional Flow MR Imaging for Complete Characterization of Cranial Dural Arteriovenous Fistulas

Myriam Edjlali, MD, Pauline Roca, PhD, Cécile Rabrait, PhD, Denis Trystram, MD, Christine Rodriguez-Régent, MD, Kevin M. Johnson, PhD, Oliver Wieben, PhD, Patrick Turski, MD, Jean-François Meder, MD, PhD, Olivier Naggara, MD, PhD, Catherine Oppenheim, MD, PhD

Cranial dural arteriovenous fistulas (DAVFs) are an uncommon but important cause of long-term morbidity and mortality, with an annual neurologic event rate of 15% (1). A DAVF is an abnormal direct connection between meningeal arteries and dural sinuses. High pressure in the sinus can result in both retrograde drainage into the venous sinus and retrograde cortical venous drainage. Digital subtraction angiography (DSA) is the standard of reference for the diagnosis and for tailoring the appropriate treatment by endovascular and/or surgical means. Apart from offering a high diagnostic performance in the detection of a DAVF, DSA enables the visualization of feeding arteries as well as the identification of the venous drainage pattern, including retrograde drainage into subarachnoid veins. The latter determines the grading of DAVF, which is important for estimating the risk of clinical complications. Importantly, the presence of retrograde cortical venous drainage or venous ectasia is considered a marker of high bleeding risk from DAVFs (1–3). However, DSA remains an invasive tool, with a potential risk, albeit very low, of severe periprocedural complications, and exposes both patients and medical staff to ionizing radiation (4). Numerous noninvasive imaging methods, such as time-resolved contrast material–enhanced magnetic resonance (MR) angiography (5) and susceptibility-weighted imaging (6,7), have demonstrated their value in the detection of DAVF. However, they all failed to enable the correct classification of DAVFs according to their bleeding risk on the basis of the Cognard classification (8). The major drawback of such MR investigations is that it is impossible to combine both optimized temporal and spatial resolution, which are necessary to appreciate the dynamic characteristics of a DAVF (eg, antegrade or retrograde venous flow) and to define precisely vessels involved in the DAVF. Accelerated four-dimensional (4D) flow imaging techniques based on phase-contrast MR imaging sequences open the possibility of capturing quantitative flow dynamics with high isotropic spatial resolution in a clinically acceptable acquisition time (9). We hypothesized that, by enabling global flow tracking in selected vessels (10), cartography of vessels implicated in cranial DAVFs could be performed. Our aim was to assess the feasibility of a selective flow-tracking cartographic procedure applied to 4D flow imaging and to demonstrate its usefulness in the characterization of DAVFs.

01 febrero 2014

RADIOLOGY. Intracranial Calcifications and Hemorrhages: Characterization with Quantitative Susceptibility Mapping

Weiwei Chen, MD, PhD, Wenzhen Zhu, MD, IIhami Kovanlikaya, MD, Arzu Kovanlikaya, MD, Tian Liu, PhD, Shuai Wang, MS, Carlo Salustri, PhD, Yi Wang, PhD

Hemorrhage and calcification are common pathologic components of many intracranial diseases. Reliable differentiation between hemorrhages and calcifications is crucial for accurate diagnosis, prognosis, and therapy optimization. For example, the presence of a hemorrhage may suggest a possible stroke, traumatic brain injury, or a malignant tumor, whereas the presence of calcifications is suggestive of different diseases, such as Sturge-Weber syndrome, tuberous sclerosis, neurocysticercosis, or craniopharyngiomas (1,2). The differentiation of intracranial microbleeds from multiple calcified cysticercus granulomas is essential for choosing an appropriate treatment for patients affected by both neurocysticercosis and hypertension (3).

01 enero 2014

AMERICAN JOURNAL OF ROENTGENOLOGY. Subarachnoid Hemorrhage: Beyond Aneurysms

Carrie P. Marder1, Vinod Narla, James R. Fink and Kathleen R. Tozer Fink

OBJECTIVE. Spontaneous subarachnoid hemorrhage (SAH) typically prompts a search for an underlying ruptured saccular aneurysm, which is the most common nontraumatic cause. Depending on the clinical presentation and pattern of SAH, the differential diagnosis may include a diverse group of causes other than aneurysm rupture.

01 enero 2014

AMERICAN JOURNAL OF ROENTGENOLOGY. Imaging Evaluation of CSF Shunts

Adam N. Wallace, Jonathan McConathy, Christine O. Menias, Sanjeev Bhalla and Franz J. Wippold II

OBJECTIVE. The objective of this article is to describe an approach to imaging CSF shunts. Topics reviewed include the components and imaging appearances of the most common types of shunts and the utility of different imaging modalities for the evaluation of shunt failure. Complications discussed include mechanical failure, infection, ventricular loculation, overdrainage, and unique complications related to each shunt type.

01 febrero 2014

AMERICAN JOURNAL OF ROENTGENOLOGY. Bone Subtraction 3D CT Venography for the Evaluation of Cerebral Veins and Venous Sinuses: Imaging Techniques, Normal Variations, and Pathologic Findings

Hyemin Seo, Dae Seob Choi, Hwa Seon Shin, Jae Min Cho, Eun Ha Koh and Seungnam Son

OBJECTIVE. Varying anatomic characteristics and clinical and radiologic manifestations are diagnostic challenges in the evaluation of the cerebral vein and of venous sinus diseases. The purpose of this article is to introduce bone subtraction CT venography and review normal variations and diseases involving the cerebral veins and venous sinuses.

12 agosto 2014

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Peripheral Vascular Disease. Comparison of Trends and Outcomes of Carotid Artery Stenting and Endarterectomy in the United States, 2001 to 2010

Luke K Kim, MD, David C. Yang, MD, Rajesh V. Swaminathan, MD, Robert M. Minutello, MD, Peter M. Okin, MD, Min Kyeong Lee, DMD, Xuming Sun, MS, S. Chiu Wong, MD, Daniel J. McCormick, DO, Geoffrey Bergman, MD, Veerasathpurush Allareddy, PhD, Harsimran Singh, MD and Dmitriy N. Feldman, MD

Background: Given the controversy regarding whether carotid endarterectomy (CEA) or carotid artery stenting (CAS) may be superior for stroke prevention, it is uncertain how recent clinical evidence, guidelines, and reimbursement policies have influenced the volume and outcomes after these procedures.

01 noviembre 2013

JACC: CARDIOVASCULAR INTERVENTIONS. Randomized Comparison of Distal and Proximal Cerebral Protection During Carotid Artery Stenting

Manuel N. Cano, MD, PhD∗; Antônio M. Kambara, MD, PhD∗; Silvia J.F. de Cano, MD∗; Luiz Antônio Pezzi Portela, MD, PhD∗; Ângela Tavares Paes, PhD∗; J. Ribamar Costa, MD∗; Alexandre Antônio Cunha Abizaid, MD∗; Samuel Martins Moreira, MD, PhD∗; Amanda G.M.R. Sousa, MD, PhD∗; J. Eduardo Moraes Rego Sousa, MD, PhD∗

Objectives: This study sought to randomly compare cerebral protection with ANGIOGUARD (Cordis Corporation, Bridgewater, New Jersey) with Mo.Ma (Invatec/Medtronic Vascular Inc, Santa Rosa, California) during carotid artery stenting (CAS), using diffusion-weighted magnetic resonance imaging (DW-MRI) to detect new ischemic cerebral lesions. The number, size, and location of lesions were analyzed.

15 noviembre 2014

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Carotid artery stenting and patient outcomes: The CABANA surveillance study

L. Nelson Hopkins MD1,*, Christopher J. White MD2, Malcolm T. Foster MD3, Richard J. Powell MD4, Gerald Zemel MD5 andJuan Diaz-Cartelle MD6

Objectives: The purpose of the prospective, multicenter, nonrandomized CABANA study was to evaluate periprocedural clinical outcomes in high surgical risk patients with carotid artery stenosis treated with the Carotid WALLSTENT plus FilterWire EZ Embolic Protection System by a diverse group of clinicians.

01 diciembre 2014

AMERICAN HEART JOURNAL. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial

Catherine M. Viscoli, PhD, Lawrence M. Brass, MDn, Antonio Carolei, MD, Robin Conwit, MD, Gary A. Ford, FRCP, Karen L. Furie, MD, MPH, Mark Gorman, MD, Peter D. Guarino, PhD, Silvio E. Inzucchi, MD, Anne M. Lovejoy, PA-C, Mark W. Parsons, MD, Peter N. Peduzzi, PhD, Peter A. Ringleb, MD, Gregory G. Schwartz, MD, PhD, J. David Spence, MD, David Tanne, MD, Lawrence H. Young, MD, Walter N. Kernan, MD on behalf of the IRIS Trial investigators

Background: Recurrent vascular events remain a major source of morbidity and mortality after stroke or transient ischemic attack (TIA). The IRIS Trial is evaluating an approach to secondary prevention based on the established association between insulin resistance and increased risk for ischemic vascular events. Specifically, IRIS will test the effectiveness of pioglitazone, an insulin-sensitizing drug of the thiazolidinedione class, for reducing the risk for stroke and myocardial infarction (MI) among insulin resistant, nondiabetic patients with a recent ischemic stroke or TIA.

01 marzo 2013

THE NEW ENGLAND JOURNAL OF MEDICINE. A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke

Chelsea S. Kidwell, M.D., Reza Jahan, M.D., Jeffrey Gornbein, Dr.P.H., Jeffry R. Alger, Ph.D., Val Nenov, Ph.D., Zahra Ajani, M.D., Lei Feng, M.D., Ph.D., Brett C. Meyer, M.D., Scott Olson, M.D., Lee H. Schwamm, M.D., Albert J. Yoo, M.D., Randolph S. Marshall, M.D., Philip M. Meyers, M.D., Dileep R. Yavagal, M.D., Max Wintermark, M.D., Judy Guzy, R.N., Sidney Starkman, M.D., and Jeffrey L. Saver, M.D. for the MR RESCUE Investigators

Multiple randomized, controlled trials have shown the efficacy of the use of intravenous tissue plasminogen activator (t-PA), administered up to 4.5 hours after the onset of symptoms of acute ischemic stroke.1,2 However, the global effect of this therapy has been limited, largely because of the narrow time window available for treatment and the risk of symptomatic intracerebral hemorrhage. Although endovascular approaches, including thrombectomy devices, have been shown to achieve greater rates of recanalization than the use of intravenous t-PA, no randomized, controlled trial has been completed comparing clinical outcomes versus standard medical care. Moreover, the potential to benefit from interventions in late time windows (≥3 hours) may be increased when they are coupled with brain imaging to select patients who are the most likely to benefit.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.